Overview
High-Yield LeukoCore™ Psoriasis Leukopaks for Immunology Research
LeukoCore™ Psoriasis Leukopak is collected from donors clinically diagnosed with psoriasis through IRB-approved apheresis procedures. Each leukopak contains large quantities of peripheral blood mononuclear cells (PBMCs), making it ideal for immune profiling, cytokine analysis, and drug development research.
Product Features
- Research Use Only (RUO) human leukopaks
- Clinically confirmed psoriasis donors
- High cell yield for large-scale studies
- Processed and shipped within 24 hours of collection
- Fresh or cryopreserved options available
- IRB-approved and ethically sourced
- Infectious disease testing
- HLA-A typing
- Screen donors with LeukoLot™
Donor Metadata
- Verified Psoriasis diagnosis from healthcare providers
- Donor demographics: age, sex assigned at birth, race/ethnicity
- Self-reported medication history and allergies
- Relevant clinical data
Applications
- Immune cell characterization in psoriasis
- Therapeutic development and screening
- Cell-based assays and cytokine profiling
- Multi-omics studies including single-cell sequencing
Compliance and Quality Assurance
- Collected under IRB oversight with donor e-consent (21 CFR Part 11 compliant)
- HIPAA-compliant handling of donor information
- Rigorous donor screening and documentation
Ordering & Customization
Psoriasis Leukopak is available fresh or cryopreserved. For international shipping or regulatory documentation, please contact to confirm regional compliance and shipping availability.
Data and Testing
Data and Testing with Every Sample
- Verified conditions
- Electronic medical records
- Infectious disease testing
- HLA-A typing
- Complete blood count (CBC)
- Certificate of Analyses (CoA)
Compliance & Quality Assured
For quality and compliance related information, please visit Sanguine quality and compliance page.
For privacy related information, please visit Sanguine privacy policy page.